Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „pembrolizumab“
Suchtreffer
Begriffe & Kennungen
Keytruda · 4.5 · No formal pharmacokinetic drug interaction studies have been conducted with pembrolizumab. Since pembrolizumab
Eintrag öffnenKeytruda · 4.5 · No formal pharmacokinetic drug interaction studies have been conducted with pembrolizumab. Since pembrolizumab
Eintrag öffnenKeytruda · 4.5 · The use of systemic corticosteroids or immunosuppressants before starting pembrolizumab should be avoided beca
Eintrag öffnenKeytruda · 4.5 · The use of systemic corticosteroids or immunosuppressants before starting pembrolizumab should be avoided beca
Eintrag öffnenKeytruda · 4.8 · 16 mesothelioma were 44% for pembrolizumab combination therapy and 30% for chemotherapy alone and in patients
Eintrag öffnenKeytruda · 4.8 · 183 Elevated liver enzymes when pembrolizumab is combined with axitinib in RCC In a clinical study of previous
Eintrag öffnenKeytruda · 4.8 · 22 treated with pembrolizumab in combination with pemetrexed and platinum chemotherapy (n=488), the incidence
Eintrag öffnenKeytruda · 4.8 · 24 In patients treated with pembrolizumab in combination with axitinib or lenvatinib, the proportion of patien
Eintrag öffnenKeytruda · 4.8 · Elevated liver enzymes when pembrolizumab is combined with axitinib in RCC In a clinical study of previously u
Eintrag öffnenKeytruda · 4.8 · Immunogenicity In clinical studies in patients treated with pembrolizumab 2 mg/kg bw every three weeks, 200 mg
Eintrag öffnenKeytruda · 4.8 · In patients treated with pembrolizumab in combination with axitinib or lenvatinib, the proportion of patients
Eintrag öffnenKeytruda · 4.8 · In patients treated with pembrolizumab in combination with chemotherapy, RT or CRT, the proportion of patients
Eintrag öffnenKeytruda · 4.8 · In patients treated with pembrolizumab in combination with chemotherapy, RT or CRT, the proportion of patients
Eintrag öffnenKeytruda · 4.8 · Intravenous formulation The safety of pembrolizumab as monotherapy has been evaluated in 161 paediatric patien
Eintrag öffnenKeytruda · 4.8 · Laboratory abnormalities In patients treated with pembrolizumab monotherapy, the proportion of patients who ex
Eintrag öffnenKeytruda · 4.8 · Laboratory abnormalities In patients treated with pembrolizumab monotherapy, the proportion of patients who ex
Eintrag öffnenKeytruda · 4.8 · Of 14 patients in KEYNOTE-204 who proceeded to allogeneic HSCT after treatment with pembrolizumab, 8 patients
Eintrag öffnenKeytruda · 4.8 · Of 14 patients in KEYNOTE-204 who proceeded to allogeneic HSCT after treatment with pembrolizumab, 8 patients
Eintrag öffnenKeytruda · 4.8 · Of 32 patients in KEYNOTE-087 who proceeded to allogeneic HSCT after treatment with pembrolizumab, 16 patients
Eintrag öffnenKeytruda · 4.8 · Of 32 patients in KEYNOTE-087 who proceeded to allogeneic HSCT after treatment with pembrolizumab, 16 patients
Eintrag öffnen